JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$3.92B |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$1.54B |
| 3 |
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
|
+$1.2B |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.1B |
| 5 |
iShares MBS ETF
MBB
|
+$780M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.34B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.3B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.6B |
| 4 |
Texas Instruments
TXN
|
+$1.53B |
| 5 |
Tesla
TSLA
|
+$1.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.53% |
| 2 | Financials | 10.45% |
| 3 | Consumer Discretionary | 10.06% |
| 4 | Healthcare | 9.81% |
| 5 | Industrials | 6.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGEN
4601
Agenus
AGEN
$315M
| $222K | ﹤0.01% |
3,561
+679
| +24% | +$50.4K |
|
|
VBIV
4602
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $221K | ﹤0.01% |
2,684
+547
| +26% | +$46.6K |
|
|
AFMD
4603
DELISTED
Affimed
AFMD
| $219K | ﹤0.01% |
3,764
+723
| +24% | +$34K |
|
4604
PUT
Alector
ALEC
$228M
| $219K | ﹤0.01% |
14,500
| – | – |
|
|
MBII
4605
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $219K | ﹤0.01% |
175,274
+120,602
| +221% | +$144K |
|
4606
PUT
Kura Oncology
KURA
$896M
| $216K | ﹤0.01% |
+6,600
| New | +$232K |
|
4607
Nordic American Tanker
NAT
$1.4B
| $216K | ﹤0.01% |
73,089
-190,424
| -72% | -$621K |
|
|
PAYA
4608
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $215K | ﹤0.01% |
15,889
-239,156
| -94% | -$2.78M |
|
4609
Maui Land & Pineapple Co
MLP
$310M
| $214K | ﹤0.01% |
18,559
+13,008
| +234% | +$148K |
|
|
MSON
4610
DELISTED
Misonix Inc
MSON
| $214K | ﹤0.01% |
17,094
+12,614
| +282% | +$159K |
|
4611
PAVmed
PAVM
$33.9M
| $213K | ﹤0.01% |
224
+166
| +286% | +$142K |
|
4612
PUT
Antero Resources
AR
$11.3B
| $212K | ﹤0.01% |
+38,900
| New | +$160K |
|
|
DVAX
4613
DELISTED
Dynavax Technologies
DVAX
| $212K | ﹤0.01% |
47,828
+8,219
| +21% | +$37.2K |
|
4614
Evolus
EOLS
$530M
| $212K | ﹤0.01% |
63,134
+54,981
| +674% | +$206K |
|
4615
Universal Technical Institute
UTI
$1.42B
| $212K | ﹤0.01% |
32,776
+22,019
| +205% | +$126K |
|
4616
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $210K | ﹤0.01% |
11,885
+1,920
| +19% | +$33.7K |
|
|
WLL
4617
PUT
DELISTED
Whiting Petroleum Corporation
WLL
| $210K | ﹤0.01% |
+8,400
| New | +$169K |
|
4618
Lindblad Expeditions
LIND
$2.26B
| $209K | ﹤0.01% |
12,239
+1,657
| +16% | +$19K |
|
4619
Aquestive Therapeutics
AQST
$533M
| $208K | ﹤0.01% |
38,863
+25,347
| +188% | +$152K |
|
|
BCEL
4620
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $207K | ﹤0.01% |
12,808
+2,312
| +22% | +$34.7K |
|
4621
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.38B
| $206K | ﹤0.01% |
3,122
+2,122
| +212% | +$129K |
|
4622
Neurogene
NGNE
$713M
| $205K | ﹤0.01% |
726
+116
| +19% | +$28.3K |
|
4623
OptimizeRx
OPRX
$165M
| $205K | ﹤0.01% |
6,578
+1,147
| +21% | +$28.1K |
|
4624
Invesco S&P 500 Pure Value ETF
RPV
$1.74B
| $205K | ﹤0.01% |
3,330
-32
| -1% | -$1.81K |
|
|
ADMS
4625
DELISTED
Adamas Pharmaceuticals
ADMS
| $205K | ﹤0.01% |
47,366
+7,131
| +18% | +$30.5K |
|
Similar funds
JP Morgan Chase's Q4 2020 Portfolio in Review
As of Q4 2020, JP Morgan Chase held 6,220 positions worth $681B, up 14% from $595B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2020 filing shows 531 new, 2,858 increased, 1,755 reduced and 504 closed positions. Its largest new stake was Apartment Income REIT Corp.: 5,811,161 shares worth $223M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2020 buy was Apartment Income REIT Corp.: 5,811,161 shares worth $223M.
- JP Morgan Chase added most to iShares Core MSCI Emerging Markets ETF in Q4 2020, an estimated $3.92B increase.
- JP Morgan Chase's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.34B.
- JP Morgan Chase fully exited Bank of America Series L in Q4 2020, selling an estimated $117M.
- JP Morgan Chase's ten largest holdings make up 16% of its $681B portfolio in Q4 2020.
- JP Morgan Chase opened 531 new positions and closed 504 in Q4 2020.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $681B.
Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.